Q2 2024 · 13F-HR
DAFNA Capital Management LLCholdings as filed
Filed 2024-08-14 · accession 0001389932-24-000016
$418.6M
Reported value
83
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78464A870 | XBI | SPDR S&P BIOTECH ETF | $41.3M | 9.86% | 445,005 | Common | SOLE |
| 85916J409 | STXS | STEREOTAXIS INC | $24.9M | 5.95% | 13,680,554 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $24.2M | 5.79% | 409,445 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $21.6M | 5.15% | 398,100 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $19.9M | 4.75% | 511,894 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $14.8M | 3.54% | 422,213 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $14.6M | 3.48% | 639,173 | Common | SOLE |
| 464287556 | IBB | ISHARES NASDAQ BIOTECH INDX | $14.1M | 3.36% | 102,500 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $13.5M | 3.22% | 657,074 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $11.3M | 2.70% | 104,763 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $11.0M | 2.64% | 80,972 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $10.7M | 2.55% | 273,739 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $10.0M | 2.40% | 189,117 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $9.9M | 2.36% | 71,615 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $9.5M | 2.27% | 806,973 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $9.2M | 2.19% | 666,463 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $8.7M | 2.08% | 423,500 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $8.2M | 1.97% | 204,208 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HOLDING INC | $7.9M | 1.89% | 231,748 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $7.9M | 1.88% | 469,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $7.6M | 1.81% | 218,730 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $7.4M | 1.78% | 65,552 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $6.8M | 1.62% | 935,894 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $5.2M | 1.25% | 290,197 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $4.6M | 1.11% | 639,974 | Common | SOLE |
| 04351PAD3 | ASND 2.25 04/01/28 | ASCENDIS PHARMA A/S | $4.4M | 1.06% | 4,000,000 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $4.4M | 1.04% | 704,500 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $4.3M | 1.04% | 1,704,232 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $4.1M | 0.99% | 912,928 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $4.0M | 0.97% | 1,050,709 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $3.9M | 0.92% | 253,217 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $3.2M | 0.77% | 130,175 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $3.2M | 0.77% | 15,900 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $3.1M | 0.74% | 67,754 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $3.1M | 0.73% | 693,609 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $2.9M | 0.69% | 120,700 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $2.8M | 0.67% | 207,427 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $2.5M | 0.60% | 274,165 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $2.5M | 0.59% | 122,200 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $2.3M | 0.55% | 231,634 | Common | SOLE |
| 004397105 | ARAY | ACCURAY INC | $2.2M | 0.53% | 1,222,358 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $2.1M | 0.51% | 144,360 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $2.0M | 0.49% | 239,194 | Common | SOLE |
| M68830112 | MDWD | MEDIWOUND LTD | $1.9M | 0.46% | 124,479 | Common | SOLE |
| 10501L106 | BWAY | BRAINSWAY LTD | $1.8M | 0.43% | 297,655 | Common | SOLE |
| 45780L104 | INGN | INOGEN INC | $1.7M | 0.41% | 208,790 | Common | SOLE |
| N44445109 | IMTX | IMMATICS NV | $1.7M | 0.40% | 145,000 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $1.6M | 0.38% | 895,200 | Common | SOLE |
| N71542109 | PRQR | PROQR THERAPEUTICS N V | $1.5M | 0.36% | 905,582 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $1.5M | 0.35% | 243,210 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $1.4M | 0.34% | 605,100 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $1.4M | 0.33% | 119,000 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $1.4M | 0.33% | 530,000 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS IN | $1.3M | 0.32% | 1,350,708 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $1.3M | 0.31% | 120,000 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $1.3M | 0.30% | 1,409,262 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $1.3M | 0.30% | 47,916 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $1.3M | 0.30% | 116,200 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $1.2M | 0.29% | 346,667 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $1.1M | 0.27% | 122,882 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $977,129 | 0.23% | 75,982 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $965,666 | 0.23% | 329,579 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $854,893 | 0.20% | 13,994 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $794,838 | 0.19% | 184,846 | Common | SOLE |
| M25722105 | CGEN | COMPUGEN LTD | $776,499 | 0.19% | 462,202 | Common | SOLE |
| B6S7WD106 | NYXH | NYXOAH S A | $753,513 | 0.18% | 108,108 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $726,000 | 0.17% | 600,000 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $703,836 | 0.17% | 121,351 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $700,986 | 0.17% | 135,850 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $644,896 | 0.15% | 204,081 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $585,660 | 0.14% | 86,000 | Common | SOLE |
| 64131A105 | STIM | NEURONETICS INC | $564,691 | 0.13% | 313,717 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $558,298 | 0.13% | 137,174 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $400,290 | 0.10% | 11,000 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $377,820 | 0.09% | 3,000 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $332,503 | 0.08% | 341,064 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $254,520 | 0.06% | 36,000 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $240,638 | 0.06% | 41,850 | Common | SOLE |
| 64157F103 | NVROEUR | NEVRO CORP | $235,760 | 0.06% | 28,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $196,350 | 0.05% | 5,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $167,167 | 0.04% | 192,678 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $162,500 | 0.04% | 125,000 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $116,882 | 0.03% | 116,882 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.